"Myelodysplastic syndrome" trang 1 - tải miễn phí từ tailieunhanh
Alterations of the expression of TET2 and DNA 5-hmC predict poor prognosis in Myelodysplastic Neoplasms

Alterations of the expression of TET2 and DNA 5-hmC predict poor prognosis in Myelodysplastic Neoplasms
18    1    1
Cytogenetic features in primary myelodysplastic syndrome Egyptian patients

Cytogenetic features in primary myelodysplastic syndrome Egyptian patients
7    51    0
Genomic copy number variations in the myelodysplastic syndrome and acute myeloid leukemia patientswith del(5q) and/or -7/del(7q)

Genomic copy number variations in the myelodysplastic syndrome and acute myeloid leukemia patientswith del(5q) and/or -7/del(7q)
8    61    0
Long non-coding RNA HOXB-AS3 promotes myeloid cell proliferation and its higher expression is an adverse prognostic marker in patients with acute myeloid leukemia and myelodysplastic syndrome

Long non-coding RNA HOXB-AS3 promotes myeloid cell proliferation and its higher expression is an adverse prognostic marker in patients with acute myeloid leukemia and myelodysplastic syndrome
14    74    0
Polish experience of lenalidomide in the treatment of lower risk myelodysplastic syndrome with isolated del(5q)

Polish experience of lenalidomide in the treatment of lower risk myelodysplastic syndrome with isolated del(5q)
6    37    1
Secondary pulmonary alveolar proteinosis complicating myelodysplastic syndrome results in worsening of prognosis: A retrospective cohort study in Japan

Secondary pulmonary alveolar proteinosis complicating myelodysplastic syndrome results in worsening of prognosis: A retrospective cohort study in Japan
10    36    1
Volasertib as a monotherapy or in combination with azacitidine in patients with myelodysplastic syndrome, chronic myelomonocytic leukemia, or acute myeloid leukemia: Summary of three phase I studies

Volasertib as a monotherapy or in combination with azacitidine in patients with myelodysplastic syndrome, chronic myelomonocytic leukemia, or acute myeloid leukemia: Summary of three phase I studies
9    32    1
Efficacy and safety of venetoclax combined with hypomethylating agents for relapse of acute myeloid leukemia and myelodysplastic syndrome post allogeneic hematopoietic stem cell transplantation: A systematic review and meta-analysis

Efficacy and safety of venetoclax combined with hypomethylating agents for relapse of acute myeloid leukemia and myelodysplastic syndrome post allogeneic hematopoietic stem cell transplantation: A systematic review and meta-analysis
12    1    1
Monitoring of post-transplant MLL-PTD as minimal residual disease can predict relapse after allogeneic HSCT in patients with acute myeloid leukemia and myelodysplastic syndrome

Monitoring of post-transplant MLL-PTD as minimal residual disease can predict relapse after allogeneic HSCT in patients with acute myeloid leukemia and myelodysplastic syndrome
11    58    3
The prognostic impact of mutations in spliceosomal genes for myelodysplastic syndrome patients without ring sideroblasts

The prognostic impact of mutations in spliceosomal genes for myelodysplastic syndrome patients without ring sideroblasts
11    27    1
Báo cáo y học:

Báo cáo y học: "A meta-analysis of CAG (cytarabine, aclarubicin, G-CSF) regimen for the treatment of 1029 patients with acute myeloid leukemia and myelodysplastic syndrome"
36    72    0
báo cáo khoa học:

báo cáo khoa học: "Phase 1-2a multicenter dose-escalation study of ezatiostat hydrochloride liposomes for injection (Telintra®, TLK199), a novel glutathione analog prodrug in patients with myelodysplastic syndrome"
12    56    0
báo cáo khoa học:

báo cáo khoa học: "Oral Ezatiostat HCl (TLK199) and Myelodysplastic syndrome: A case report of sustained hematologic response following an abbreviated exposure"
3    104    0
Artesunate induces SKM-1 cells apoptosis by inhibiting hyperactive β-catenin signaling pathway

Artesunate induces SKM-1 cells apoptosis by inhibiting hyperactive β-catenin signaling pathway
6    55    0
FOXP1 and TP63 involvement in the progression of myelodysplastic syndrome with 5q- and additional cytogenetic abnormalities

FOXP1 and TP63 involvement in the progression of myelodysplastic syndrome with 5q- and additional cytogenetic abnormalities
6    33    1
The importance of evaluating specific myeloid malignancies in epidemiological studies of environmental carcinogens

The importance of evaluating specific myeloid malignancies in epidemiological studies of environmental carcinogens
22    25    1
A novel scoring system integrating molecular abnormalities with IPSS-R can improve the risk stratification in patients with MDS

A novel scoring system integrating molecular abnormalities with IPSS-R can improve the risk stratification in patients with MDS
9    45    1
Safety of bronchoscopy in patients with malignant hematologic disorders

Safety of bronchoscopy in patients with malignant hematologic disorders
6    21    1
Aberrant methylation of the M-type phospholipase A2 receptor gene in leukemic cells

Aberrant methylation of the M-type phospholipase A2 receptor gene in leukemic cells
10    43    1
Secondary pulmonary alveolar proteinosis: A single-center retrospective study (a case series and literature review)

Secondary pulmonary alveolar proteinosis: A single-center retrospective study (a case series and literature review)
7    29    1